Papillary thyroid microcarcinoma should not be used as the basis for postoperative 131I therapy
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 6
Abstract
[Objective] To analyze the clinicopathological data of patients with papillary thyroid microcarcinoma (PTMC) and papillary thyroid non-microcarcinoma (non-PTMC) who received 131I therapy retrospectively, and compare the therapeutic response of the two groups of patients, so as to guide 131I therapy decisions for PTMC patients. [Methods] A total of 1 118 patients with papillary thyroid carcinoma (PTC) underwent 131I therapy in the Department of Nuclear Medicine, Tianjin Medical University General Hospital from January 2015 to December 2020 were enrolled. Chi-square test and Mann-Whitney U test were used to compare the differences of clinicopathological features and 131I therapy， therapeutic response between two groups. The incomplete response （IR）rate curves of the two groups were plotted by Kaplan-Meier analysis.[Results] The proportion of patients with multifocal, involvement of bilateral thyroid lobes in PTMC group were higher than those in non-PTMC group, and the proportion of patients with extra-thyroid extension, T4, N1b, stimulated thyroglobulin(sTg)>10 μg/L, and high risk stratified were lower than those in non-PTMC group (P<0.05). Most patients in PTMC group received remnant ablation for the first time, while more patients in non-PTMC group received adjuvant therapy and therapy for known disease (P<0.05). There was no statistically significant difference in 131I therapeutic response, the rates of excellent response(ER) and IR in two groups, and the differences in curves of IR rate between the two groups were also no statistically significance (P>0.05). [Conclusions] PTMC has a certain degree of invasiveness. As long as the patients were comprehensively evaluated and the standard 131I therapy was adopted, the treatment outcomes of patients with PTMC and non-PTMC were roughly the same. Therefore, the clinical value of the definition of PTMC is extremely limited in the formulation of 131I therapeutic dose regimens.
Authors and Affiliations
Xiaoyu CAI, Ruiguo ZHANG, Yujing HU, Renfei WANG, Yanzhu BIAN
Keywords
Related Articles
- EP ID EP750926
- DOI 10.16139/j.1007-9610.2023.06.08
- Views 28
- Downloads 1
<![CDATA[Application of 21-Gene test in adjuvant radiotherapy for early breast cancer]]>
<![CDATA[Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of pe...
Interpretation of the updated international guidelines for groin hernia management (2023)
Since the International guidelines for groin hernia management were published in 2018, many new evidences have been published. In October 2023, the HerniaSurge Group published Update of the international HerniaSurge guid...
Research on the management of the Glissonean pedicle in laparoscopic anatomical hemihepatectomy and the influence of indocyanine green dose on the fluorescence staining effect
[Objective] To investigate the technique and dosage selection of indocyanine green(ICG) fluorescence staining in laparoscopic anatomical hemihepatectomy. [Methods] A retrospective cross-sectional study was conducted. The...
Comparative analysis between air-free trans-axillary laparoscopic thyroidectomy and open thyroidectomy
[Objective] To compare the clinical efficacy between air-free trans-axillary laparoscopic thyroidectomy and open thyroidectomy. [Methods] A retrospective analysis was performed on the data of both 96 patients who underwe...
Stage on development of pathophysiology of gallbladder stone and personalized diagnosis and treatment
Gallbladder stone (GS) is a common disease. There are no obvious symptoms at early stage for the patient with GS. Obstruction will cause acute cholecystitis. Secondary obstructive cholangitis of GS, biliary pancreatitis,...